Drug Profile
U 37883A
Alternative Names: PNU 37883ALatest Information Update: 13 Mar 2000
Price :
$50
*
At a glance
- Originator Pharmacia Corporation
- Class Antihypotensives; Morpholines
- Mechanism of Action KATP channel inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypotension
Most Recent Events
- 13 Mar 2000 No-Development-Reported for Hypotension in USA (Unknown route)
- 25 Sep 1995 New profile
- 25 Sep 1995 Preclinical development for Hypotension in USA (Unknown route)